National Wind Erosion Research Network: Building a standardized long-term data resource for aeolian research, modeling and land management von Webb, Nicholas P, Jeffrey E. Herrick, Justin W. Van Zee, Ericha M. Courtright, Christopher H. Hugenholtz, Ted M. Zobeck, Gregory S. Okin, Thomas E. Barchyn, Benjamin J. Billings, Robert Boyd, Scott D. Clingan, Brad F. Cooper, Michael C. Duniway, Justin D. Derner, Fred A. Fox, Kris M. Havstad, Philip Heilman, Valerie LaPlante, Noel A. Ludwig, Loretta J. Metz, Mark A. Nearing, M. Lee Norfleet, Frederick B. Pierson, Matt A. Sanderson, Brenton S. Sharratt, Jean L. Steiner, John Tatarko, Negussie H. Tedela, David Toledo, Robert S. Unnasch, R. Scott Van Pelt, Larry Wagner

Volltext

A decrease in radiative forcing and equivalent effective chlorine from hydrochlorofluorocarbons von Western, Luke M., Daniel, John S., Vollmer, Martin K., Clingan, Scott, Crotwell, Molly, Fraser, Paul J., Ganesan, Anita L., Hall, Brad, Harth, Christina M., Krummel, Paul B., Mühle, Jens, O’Doherty, Simon, Salameh, Peter K., Stanley, Kieran M., Reimann, Stefan, Vimont, Isaac, Young, Dickon, Rigby, Matt, Weiss, Ray F., Prinn, Ronald G., Montzka, Stephen A.

Volltext

Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer von Church, Timothy R, Black, William C, Aberle, Denise R, Berg, Christine D, Clingan, Kathy L, Duan, Fenghai, Fagerstrom, Richard M, Gareen, Ilana F, Gierada, David S, Jones, Gordon C, Mahon, Irene, Marcus, Pamela M, Sicks, JoRean D, Jain, Amanda, Baum, Sarah

Volltext

Whole–genome characterization of chemoresistant ovarian cancer von Patch, Ann-Marie, Christie, Elizabeth L., Etemadmoghadam, Dariush, Garsed, Dale W., George, Joshy, Fereday, Sian, Nones, Katia, Cowin, Prue, Alsop, Kathryn, Bailey, Peter J., Kassahn, Karin S., Newell, Felicity, Quinn, Michael C. J., Kazakoff, Stephen, Quek, Kelly, Wilhelm-Benartzi, Charlotte, Curry, Ed, Leong, Huei San, Hamilton, Anne, Mileshkin, Linda, Au-Yeung, George, Kennedy, Catherine, Hung, Jillian, Chiew, Yoke-Eng, Harnett, Paul, Friedlander, Michael, Quinn, Michael, Pyman, Jan, Cordner, Stephen, O’Brien, Patricia, Leditschke, Jodie, Young, Greg, Strachan, Kate, Waring, Paul, Azar, Walid, Mitchell, Chris, Traficante, Nadia, Hendley, Joy, Thorne, Heather, Shackleton, Mark, Miller, David K., Arnau, Gisela Mir, Tothill, Richard W., Holloway, Timothy P., Semple, Timothy, Harliwong, Ivon, Nourse, Craig, Nourbakhsh, Ehsan, Manning, Suzanne, Idrisoglu, Senel, Bruxner, Timothy J. C., Christ, Angelika N., Poudel, Barsha, Holmes, Oliver, Anderson, Matthew, Leonard, Conrad, Lonie, Andrew, Hall, Nathan, Wood, Scott, Taylor, Darrin F., Xu, Qinying, Fink, J. Lynn, Waddell, Nick, Drapkin, Ronny, Stronach, Euan, Gabra, Hani, Brown, Robert, Jewell, Andrea, Nagaraj, Shivashankar H., Markham, Emma, Wilson, Peter J., Ellul, Jason, McNally, Orla, Doyle, Maria A., Vedururu, Ravikiran, Stewart, Collin, Lengyel, Ernst, Pearson, John V., Waddell, Nicola, deFazio, Anna, Grimmond, Sean M., Bowtell, David D. L.

Volltext

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled... von Fizazi, Karim, Prof Dr, Scher, Howard I, Prof, Molina, Arturo, MD, Logothetis, Christopher J, Prof, Chi, Kim N, MD, Jones, Robert J, PhD, Staffurth, John N, MD, North, Scott, MD, Vogelzang, Nicholas J, MD, Saad, Fred, Prof, Mainwaring, Paul, MD, Harland, Stephen, MD, Goodman, Oscar B, MD, Sternberg, Cora N, MD, Li, Jin Hui, PhD, Kheoh, Thian, PhD, Haqq, Christopher M, MD, de Bono, Johann S, Prof

Volltext

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma von Kondrashova, Olga, Topp, Monique, Nesic, Ksenija, Lieschke, Elizabeth, Ho, Gwo-Yaw, Harrell, Maria I., Zapparoli, Giada V., Hadley, Alison, Holian, Robert, Boehm, Emma, Heong, Valerie, Sanij, Elaine, Pearson, Richard B., Krais, John J., Johnson, Neil, McNally, Orla, Ananda, Sumitra, Alsop, Kathryn, Hutt, Karla J., Kaufmann, Scott H., Lin, Kevin K., Harding, Thomas C., Traficante, Nadia, deFazio, Anna, McNeish, Iain A., Bowtell, David D., Swisher, Elizabeth M., Dobrovic, Alexander, Wakefield, Matthew J., Scott, Clare L.

Volltext

Abiraterone and Increased Survival in Metastatic Prostate Cancer von de Bono, Johann S, Logothetis, Christopher J, Molina, Arturo, Fizazi, Karim, North, Scott, Chu, Luis, Chi, Kim N, Jones, Robert J, Goodman, Oscar B, Saad, Fred, Staffurth, John N, Mainwaring, Paul, Harland, Stephen, Flaig, Thomas W, Hutson, Thomas E, Cheng, Tina, Patterson, Helen, Hainsworth, John D, Ryan, Charles J, Sternberg, Cora N, Ellard, Susan L, Fléchon, Aude, Saleh, Mansoor, Scholz, Mark, Efstathiou, Eleni, Zivi, Andrea, Bianchini, Diletta, Loriot, Yohann, Chieffo, Nicole, Kheoh, Thian, Haqq, Christopher M, Scher, Howard I

Volltext

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance von Nesic, Ksenija, Krais, John J, Wang, Yifan, Vandenberg, Cassandra J, Patel, Pooja, Cai, Kathy Q, Kwan, Tanya, Lieschke, Elizabeth, Ho, Gwo-Yaw, Barker, Holly E, Bedo, Justin, Casadei, Silvia, Farrell, Andrew, Radke, Marc, Shield-Artin, Kristy, Penington, Jocelyn S, Geissler, Franziska, Kyran, Elizabeth, Betsch, Robert, Xu, Lijun, Zhang, Fan, Dobrovic, Alexander, Olesen, Inger, Kristeleit, Rebecca, Oza, Amit, McNeish, Iain, Ratnayake, Gayanie, Traficante, Nadia, DeFazio, Anna, Bowtell, David D L, Harding, Thomas C, Lin, Kevin, Swisher, Elizabeth M, Kondrashova, Olga, Scott, Clare L, Johnson, Neil, Wakefield, Matthew J

Volltext

A phase I, first-in-human, open-label, dose-escalation study of MGD013, a bispecific DART molecule binding PD-1 and LAG-3, in patients with unresectable or metastatic neoplasms von Luke, Jason J., Patel, Manish R., Hamilton, Erika Paige, Chmielowski, Bartosz, Ulahannan, Susanna Varkey, Kindler, Hedy L., Bahadur, Shakeela Wazeen, Clingan, Philip R., Mallesara, Girish, Weickhardt, Andrew James, Currence, Scott, Xu, Linzhi, Kaul, Sanjeev, Chen, Francine, Moore, Paul A., Bonvini, Ezio, Sumrow, Brad, Blumenschein, George

Volltext

A randomized double-blind trial of carboplatin plus paclitaxel (CP) with daily oral cediranib (CED), an inhibitor of vascular endothelial growth factor receptors, or placebo (PLA)... von Laurie, Scott Andrew, Solomon, Benjamin J., Seymour, Lesley, Ellis, Peter Michael, Goss, Glenwood D., Shepherd, Frances A., Boyer, Michael J., Arnold, Andrew Michael, Clingan, Philip, Laberge, Francis, Fenton, Dave, Hirsh, Vera, Zukin, Mauro, Stockler, Martin R., Lee, Christopher W., Chen, Eric Xueyu, Montenegro, Alexander, Ding, Keyue, Bradbury, Penelope Ann

Volltext

Selected Cliometric Studies on German Economic History von Clingan, C. Edmund

Volltext